Mumbai, 25 Jan 2023: As domestic pharma players race to launch the generic version of Novartis’ blockbuster heart failure drug after its patent expiry, Mankind Pharma reduced the price of its drug, NEPTAZ, by 70 percent in India.

 

The patent of Novarti......
View Details

Related News

• CDSCO says samples labelled as Cipla's and Sun Pharma's drugs failed in July could be spurious (25-09-2023)

---

• Govt in process of identifying additional regulatory interventions to stop Misuse of Antimicrobials (25-09-2023)

---

• Resistance to last-resort antibiotics Carbapenem growing in India: ICMR report (25-09-2023)

---

• 4 arrested with 375 bottles of Eskuf cough syrup worth Rs 4 lakh (25-09-2023)

---

• Ghaziabad: Fake Augmentin 625 Duo and Ultracet worth Rs 8 lakh seized, four arrested (24-09-2023)

---

• Police recovered 292 intoxicating capsules and 5760 pills in Ambala (24-09-2023)

---

• One Arrested by Cachar Police with 18,000 Yaba Tablets (24-09-2023)

---

• Indian-origin girl receives first rejection-free kidney from mother in UK (24-09-2023)

---

• 3D-printed medical devices gain ground (24-09-2023)

---

• Consignment of banned medicines seized in Rewari: Mother and son were running business (23-09-2023)

---